$3.18
At close: Jul 17, 5:00 PM EST
$3.20
0.020.63%
After Hours: Jul 10, 7:06 PM EST
Esperion Therapeutics Inc Earnings Estimates
ESPRNASDAQ
Esperion Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ESPR
Esperion Therapeutics (ESPR) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-0.06 and quarterly revenue of $80.07M.
In the most recent quarter (Q1), Esperion Therapeutics reported EPS of $-0.10, missing estimates of $-0.03 by 2.33%. Revenue came in at $80.10M, missing the estimate of $84.58M by 0.05%.
Esperion Therapeutics has missed EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Esperion Therapeutics has averaged an EPS surprise of 1.16% and a revenue surprise of 0.11%.
Earnings Date
Aug 4
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$80.07M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$418.24M
Esperion Therapeutics Earnings History
Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.
Loading calendar...
Esperion Therapeutics (ESPR) Earnings Per Share
The chart below shows Esperion Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Esperion Therapeutics (ESPR) Revenue
The chart below shows Esperion Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?
Esperion Therapeutics (ESPR) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 7, 2026 for Q1.
What were the latest earnings per share (EPS) for Esperion Therapeutics (NASDAQ:ESPR)?
The Actual EPS was $-0.10, which missed the estimate of $-0.03.
What were Esperion Therapeutics’s (NASDAQ:ESPR) revenues?
The Actual Revenue was $80.10M, which missed the estimate of $84.58M.
